Select Medical Holdings Corporation
NYSE:SEMMedical - Care Facilities
+$0.02 today
- Market cap
- $2.05B
- Beta
- 0.79
- P/E (TTM)
- 15.3
- EPS (TTM)
- $1.08
- Dividend yield
- 1.51%
Volume 14.27M
Average 1.75M
SEM EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Select Medical Holdings CorporationNYSE: SEM
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA dips below year-ago levels
Q1 FY2026 EBITDA of $147.68M fell 7.7% year over year, behind the +57.7% change in trailing-twelve-month EBITDA. Sequentially, it rose 28.1% from the prior quarter. Over 3 fiscal years it compounded at -5.8% a year.
Context
- EBITDA amounted to 9.7% of revenue in FY2025, unchanged from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 4 analysts of $649.3M (+22.4%) for the fiscal year ending Dec 2026, a step up from the +4.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $147.68M+28.1% QoQ
- Last fiscal yearDec 2025
- $530.64M+4.6% YoY
- LTMMar 2026
- $518.25M+57.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -7.7% | +18.0% | +25.7 pp |
| 1 year | +4.6% | +22.4% | +17.8 pp |
| 3-year CAGR | -5.8% | +10.5% | +16.3 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 530.64M USD
- Year-over-year change
- +4.6%
- 4-year CAGR
- -14.0%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 530.64M | +4.6% |
| FY2024 | 2024-12-31 | 507.27M | -35.8% |
| FY2023 | 2023-12-31 | 789.74M | +24.3% |
| FY2022 | 2022-12-31 | 635.52M | -34.4% |
| FY2021 | 2021-12-31 | 968.35M | — |
EBITDA vs competitors
How SEM compares with its peers on the latest reported figures
- SEM's LTM Mar 2026 EBITDA of $518.25M is the highest of the 11 companies compared; the peer median is $185.33M.
- Its year-over-year change of +57.7% is the 2nd highest of 11, against a peer median of +11.6%.
- EBITDA amounts to 9.4% of revenue for SEM, versus a peer median of 12.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $518.25M | +57.7% | -5.8% | 9.4% | |
ARDTArdent Health Partners, LLC | LTM Mar 2026 | $505.76M | -10.5% | -2.2% | 7.9% |
| LTM Oct 2026 | $347.65M | +31.1% | — | 13.0% | |
| LTM Jun 2026 | $276.39M | +4.3% | +20.2% | 28.8% | |
| LTM Sep 2026 | $250.01M | -3.2% | +20.5% | 12.8% | |
| LTM Sep 2026 | $207.86M | +10.1% | +46.3% | 13.1% | |
| LTM Mar 2026 | $162.81M | +26.3% | +6.5% | 4.6% | |
| LTM Jun 2026 | $131.66M | +132.4% | — | 8.3% | |
| LTM Mar 2026 | $103.54M | +13.1% | +13.0% | 14.2% | |
| LTM Mar 2026 | $96.4M | +28.0% | +11.1% | 5.2% | |
| LTM Sep 2026 | -$664.91M | -246.0% | — | 19.5% | |
| Peer median (excluding SEM) | $185.33M | +11.6% | +13.0% | 12.9% | |
Competitors are the stored peer set for SEM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 6.2B | 6.33B | 6.66B | 5.19B | 5.45B |
| Cost of Revenue | 5.29B | 5.6B | 5.73B | 4.55B | 4.82B |
| Gross Profit | 919.37M | 733.38M | 932.04M | 633.64M | 629.3M |
| Gross Margin | 14.8% | 11.6% | 14.0% | 12.2% | 11.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 146.98M | 153.04M | 170.19M | 225.87M | 154.41M |
| Operating Expenses | 205.59M | 330.09M | 377.17M | 365.33M | 294.72M |
| Depreciation & Amortization | 202.65M | 205.83M | 208.74M | 203.89M | 140.3M |
| EBITDA | 968.35M | 635.52M | 789.74M | 507.27M | 530.64M |
| EBITDA Margin | 15.6% | 10.0% | 11.9% | 9.8% | 9.7% |
| Operating Income | 713.77M | 403.28M | 554.87M | 268.32M | 334.58M |
| Operating Margin | 11.5% | 6.4% | 8.3% | 5.2% | 6.1% |
| Interest Income | 5.35M | 0 | 0 | 0 | 0 |
| Interest Expense | 135.99M | 169.11M | 198.64M | 128.61M | 117.58M |
| Other Income / Expenses | (84.05M) | (142.7M) | (172.52M) | (93.55M) | (61.83M) |
| Income Before Tax | 629.72M | 260.58M | 382.36M | 174.77M | 272.75M |
| Pre-Tax Margin | 10.1% | 4.1% | 5.7% | 3.4% | 5.0% |
| Income Tax Expense | 129.77M | 62.55M | 82.63M | 44.78M | 58.22M |
| Net Income | 402.23M | 158.99M | 243.49M | 214.04M | 146.22M |
| Net Margin | 6.5% | 2.5% | 3.7% | 4.1% | 2.7% |
| EPS (Basic) | 2.99 | 1.23 | 1.91 | 1.66 | 1.18 |
| EPS (Diluted) | 2.99 | 1.23 | 1.91 | 1.66 | 1.18 |
| Weighted Avg Shares | 130.25M | 124.63M | 123.11M | 129.19M | 123.51M |
| Weighted Avg Shares (Diluted) | 130.25M | 124.63M | 123.11M | 124.61M | 123.51M |
Select Medical Holdings Corporation
NYSE:SEM
Intrinsic Alpha fair value
Locked
Current Price
$16.51
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.